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Specific  immune  T  lymphocytes play  an  important  role  in  the  resistance  to  a 
variety of viral  diseases  (1).  In the case of spontaneous recovery from Friend  virus 
(FV)Linduced  leukemia,  the  appearance  of FV-specific  cytotoxic T  lymphocytes 
closely correlates with regression of leukemic splenomegaly (2). Furthermore, recovery 
from FV leukemia has been shown to be strongly influenced by an H-2D-associated 
gene,  Rfv-1  (3).  After high  FV  doses,  mice  of the  H-2D  b/b  genotype have  a  high 
incidence of recovery from FV leukemia, whereas mice of the H-2D  d/b and H-2D  d/d 
genotypes have a  low incidence of recovery (3,  4).  The mechanism of this  genetic 
influence on recovery is unknown, however, previous findings suggested that the H- 
2D region might control the T  lymphocyte response to FV (5). We recently showed 
that shortly after inoculation with a  low dose of FV, mice of both the H-2D  b/b and 
H-2D  d/b genotypes developed cytotoxic T  lymphocytes (CTL) that recognized FV in 
association with their respective H-2D gene products.  2 These findings indicated that 
both  genotypes could develop  an  appropriate  CTL response and  suggested  that  a 
more subtle, perhaps quantitative difference in this response to FV might account for 
the  differences  in  recovery observed  between  mice  of the  H-2D  b/b  and  H-2D  d/b 
genotypes after high FV doses. 
To study quantitative aspects of the T  lymphocyte response to FV in these mice, 
we developed an FV-specific T  lymphocyte proliferative assay (6).  In contrast to the 
assay for FV-specific CTL, this assay allowed us to detect a  T  lymphocyte response 
even in the presence of FV leukemia cells.  Our results indicated that  H-2D  a/b mice 
had a significantly delayed development of the FV-specific T lymphocyte proliferative 
response as compared with congenic H-2D  b/b mice. This delay was mapped to the D 
region of H-2, and  could explain  the differences in  recovery incidence observed in 
these mice after high virus doses.  Furthermore, congenic H-2  a/a mice never developed 
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a significant FV-specific T  lymphocyte response. This lack of responsiveness was virus- 
specific and mapped to the left of the D  region of H-2. 
Materials and Methods 
Animals.  The following mice were purchased from The ,Jackson  Laboratory, Bar Harbor, 
ME:  C57BL/10Sn, H-2  b -- KbDb; B10.A,  H-2  a ~=  KkDa;  B10.A(2R), H-2  ~  -  KkDb; A.BY, 
H-2  b =  KbDb;  and A/WySn, H-2  a =  KkD  a.  F1 hybrids were bred at  the Rocky Mountain 
Laboratories, Hamilton, MT. Mice used in all experiments were between 2 and 4 mo of age. 
Cells and Virus.  The B-tropic strain of Friend virus complex (FV) was obtained from Dr. F. 
Lilly, Albert Einstein School of Medicine, Bronx, NY. The virus stocks  used for inoculation 
were prepared in (C57BL/10Sn ×  A.BY)Fx mice and assayed as previously described (3). The 
origins and properties of the FV leukemia cell lines AA41 and clone 2C of Y57 (Y57-2C) have 
been described (2, 7). Cell lines were maintained in RPMI  1640 supplemented with 4% fetal 
calf serum (FCS)  and 2-mercaptoethanol at a final concentration of 2 ×  10  -5 M. 
Elimination of Cells Expressing Thy-1 Antigen.  Depletion of Thy-1 antigen-positive cells using 
monoclonal rat anti-Thy-1 antibody and rabbit serum as a source of complement (C') has been 
described previously (8). 
Concanavalin A Stimulation of Spleen Cells.  Nylon wool nonadherent spleen cells were added to 
96-well flat bottom microtiter plates in 0.2 ml of Click's media (9), supplemented with 5% FCS. 
0.025  ml of Click's media plus 1.0/~g of Coneanavalin A  (Con A)  (Miles-Yeda Laboratories, 
Rehovot, Israel)  was added. The cultures were incubated for 48 h  at  37°C in a  humidified 
atmosphere containing 5%  CO2,  pulsed with  t  /~Ci [3H]thymidine (New  England Nuclear, 
Boston, MA)  for  12 h  and harvested on a  MASH II (Microbiological Associates,  Bethesda, 
MD). The cpm incorporated was determined. Wells containing no Con A were considered to 
be background and were consistently between 1,000-2,000  cpm ±  10%. The response to Con A 
was usually in the range of 200,000-250,000 cpm. 
FV-Specific  T  Lymphocyte Proliferation Assay.  This assay has been described previously (6). 
Briefly,  100-200 ×  10  s spleen cells were passaged over nylon wool columns. Nonadherent cells 
were washed  twice with phosphate-buffered balanced salt solution (PBBS),  resuspended in 
Click's media supplemented v~ith 5% FCS (screened for low background stimulation). 5 ×  105 
cells  were  added  to  flat  bottom mierotiter wells  containing 1 ×  105  mitomycin C  (Sigma 
Chemical Co., St. Louis, MO)-treated Y57-C2 or AA41 leukemia cells. The total volume of the 
culture was 0.2 ml. The cultures were incubated for 4 d at 37°C in a humidified atmosphere 
containing 5% CO2.  The cultures were then pulsed with  1 #Ci [3H]thymidine for  12 h  and 
harvested. Control cultures containing  only nylon wool nonadherent cells and no mitomycin C- 
treated  leukemia cells  (media  only)  were  considered  background cpm  incorporated.  The 
background counts consistently ranged between 1,000 and 3,000 cpm. If the background counts 
were  outside of these  limits, individual mice were  excluded  from  the  study.  Results were 
expressed as Acpm, calculated by subtracting cpm of unstimulated control cultures from cpm 
of cultures stimulated with mitomycin C-treated leukemia cells. 
Greater than 90% of the nylon wool nonadherent cells expressed  cell surface Thy-1, and 
depletion of the  nylon wool  nonadherent cells  with  anti-Thy-1 and  rabbit C'  completely 
abrogated the FV-specific proliferative response. Therefore, the cells proliferating in the cultures 
appeared  to be T  lymphocytes. In addition, membrane immunofluorescence studies of the 
proliferating cells 4 d after mixing with mitomycin C-treated FV leukemia cells revealed that 
~80-90% expressed Lyt-1 and <10% expressed  Lyt-2 (data not shown). 
Statistical Methods.  To determine a  significant response above background incorporation, 
normal (C57BL/10Sn × A.BY)F1 and (B10.A × A.BY)F1 mice were stimulated with mitomyein 
C-treated Y57-2C leukemia cells. The Acpm from 32 normal (C57BL/10Sn ×  A.BY)F1 and 28 
normal (B10.A ×  A.BY)F1 mice were determined. The results from both strains of mice were 
pooled, as no significant differences were observed. The mean and standard deviation were 
calculated. The result of this calculation was 2,000 ±  300, thus giving a 99% confidence interval 
(3 standard deviations) of ~ 1,000-3,000.  Mice whose cells incorporated >3,000 cpm were thus 
considered significantly different from normal mice. Similar methods were used to determine 
a  confidence interval for the proliferative response of (B10.A  ×  A/WySn)F1 mice when the 
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Results 
Lack of Suppression of the T  Lymphocyte Response to Con A  in F1 Congenic Mice Inoculated 
With  Friend  Virus.  Earlier  reports  suggested  that  mice  with  FV-induced  leukemic 
splenomegaly showed suppression  of various T  lymphocyte functions such as the  in 
vitro responses to Con A, phytohemagglutinin,  and allogeneic cells, and in vivo skin 
allograft and tumor homograft rejection (10-12). However, using nylon wool-purified 
splenic T  lymphocytes, Kumar et al. (13) found no suppression of Con A responsiveness 
in the presence of FV or FV leukemia cells. Although we showed previously that anti- 
FV antibody production was unimpaired  even in the  presence of massive leukemic 
splenomegaly  in  F1  mice  of  the  Rfv-3  r/~  genotype,  we  did  not  directly  test  T 
lymphocyte function in these mice (14). Therefore, to determine the effect of FV on 
T  lymphocyte  reactivity,  we  measured  the  proliferative  response  of  nylon  wool 
nonadherent  spleen  cells to Con A  at various times after intravenous inoculation of 
mice with  1,000 spleen  focus-forming units  (SFFU)  of FV-B.  The majority of mice 
tested had responses comparable to normal, uninoculated, syngeneic mice (Fig.  1), in 
spite of the fact that mice of the H-2D  a/b and H-2D  a/a genotypes were grossly leukemic 
(spleen weight >1.0 g) by day 18 postvirus inoculation. 
Mice of the H-2D a/b Genotype Generate a T Lymphocyte Proliferative Response to FV During 
Progressive Leukemia.  Once  we  found  that  splenic  T  lymphocytes  of FV-infected 
~o~  .  81Ii  I  |  "  "  lOO~-  ~  ~  ~II  °  o  . 
1 
Z  75%- 
,,-I 
n- 
O 
z 
u.. 
0  50%' 
LU 
CO 
Z 
0  G. 
O3 
LU 
25%" 
O@  0 
o 
o@ 
5  10  15  20  25  30  35 
DAYS  POST  FV 
Fro.  I.  (©), (C57BL/10Sn  X A.BY)Fx, H-2Db/b; (D), (B10.A ×  A.BY)F1, H-2Dd/b; and  (A), 
(B10.A × A/WySn)F1, H-2Dd/a; mice were given i.v. 1,000 FFU of FV-B. On the days indicated 
after inoculation, nylon wool nonadherent spleen cells were cultured with 1 #g of  Con A as described 
in Materials and Methods. The results are expressed as the percent response of nylon wool enriched 
spleen cells from a normal, uninoculated syngeneic animal cultured under the same conditions on 
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leukemic H-2D  d/b mice could respond to Con A, we then tested whether these mice 
could  generate  a  T  lymphocyte response  specific  for FV  antigens.  Mice  with  the 
H-2D  d/b  genotype  had  leukemic  splenomegaly  at  the  time  of analysis,  but  most 
generated  a  significant  FV-specific T  lymphocyte response equal  in  magnitude  to 
H-2D  b/b mice that had recovered from leukemia (Fig. 2). Therefore, the low incidence 
of recovery in mice of the H-2D  a/b genotype could not simply he ascribed to a failure 
to mount a T  lymphocyte response to FV. 
H-2D a/b  Mice Exhibit  a  Delayed  Development  of the  T  Lymphocyte  Response to  FV as 
Compared  with  H-2D bib  Mice.  Our  previous  findings  demonstrated  that  mice  of 
H-2D  a/b genotype had a  high incidence of recovery if inoculated with a  low dose of 
FV  (10-20  FFU),  but  failed to recover if inoculated  with a  high virus dose  (1,000- 
2,000 FFU)  (4). These results suggested that H-2D  d/b mice could develop the effector 
mechanisms necessary for recovery from FV leukemia, and that the effect of FV dose 
on recovery might be explained by quantitative or kinetic aspects of the FV-specific 
immune response rather than  the presence or absence of such responses. Therefore, 
we investigated the kinetics of the development of the T  lymphocyte response to FV 
in  H-2D  b/b and H-2D  d~' mice after a  high FV dose.  The majority of H-2D  b/b mice 
exhibited  a  T  lymphocyte proliferative response to  FV  as  early as  6  d  after virus 
inoculation and by day  10 >90% of mice examined had a  significant T  lymphocyte 
response  (Fig.  3  and Table  I).  In contrast,  only a  small  percentage of mice of the 
H-2D  dm  genotype  developed  a  T  lymphocyte  response  before  day  16  after  virus 
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Fxc.  3.  (O),  (C57BL/10Sn  X  A.BY)F1, H-2Db/b;  (O),  (B10.A  X  A.BY)F1, H-2Dam;  and  (A), 
(B10.A(2R)  X A.BY)F1, H-2Db/b; were given i.v.  1,000 FFU of FV-B. At various days after virus 
inoculation, nylon wool  nonadherent  spleen cells were cultured with mitomycin C-treated Y57- 
clone 2C FV leukemia cells for 4 d. Cultures were pulse labeled with [nH]thymidine,  harvested, and 
Acpm incorporated was determined as described  in Materials and Methods. Values >3,000 Acpm 
were considered significant responses. 
TABLE  I 
Accelerated Development of an FV-Specific  T Lymphocyte Proliferative Response Maps to the D Region of 
H-2 
Strain 
H-2 Genotype  Responders/total number tested* 
K  I  S  D  5-10d$  11-16d$  17-40d$ 
(BIO x  A.BY)F1  b/b  b/b  b/b  b/b  11/12  (90%)  16/16  (100%)  4/4  (I00%) 
(B10.A(2R)  x  A.BY)Fx  k/b  k/b  d/b  b/b  7/8  (88%)  NT  NT 
(B10.A X A.BY)F1  k/b  k/b  d/b  d/b  1/9  (13%)  3/13 (23%)  11/12  (92%) 
* Nylon  wool-passed  splenic  lymphocytes  were cultured  with  mitomycin C-treated  Y57-clone  2C  FV 
leukemia cells  for 4  d.  After a  12-h pulse  with  1 /aCi [aH]thymidine,  cells  were collected and  cpm 
incorporated into DNA was measured. A response above 3,000 Acpm was considered  significant. 
~: Number of days between FV inoculation (1,000 FFU FV-B, i.v.) and assay of T lymphocyte response. 
NT, not tested. 
inoculation  (Fig.  3  and  Table  I);  however,  almost  all  of these  mice  developed  a 
significant  T  lymphocyte  response  to  FV  when  tested  later  than  16  d  after  virus 
inoculation  (Fig.  3).  The  lack of an  FV-specific T  lymphocyte  response  in  H-2D d/b 
mice before day  16 could not be attributed to general suppression of all T  lymphocyte 
reactivity,  as  the  lymphocytes  of  these  same  mice  had  a  normal  response  when 
stimulated with Con A  (Fig.  1). 
To determine which region of the H-2 complex influenced the rate of development BRITT  ET  AL.  1741 
of the T  lymphocyte response to FV, we investigated the FV-specific T  lymphocyte 
response in  (B10.A(2R)  ×  A.BY)F1  mice  (H-2Dbm).  These mice differed from the 
(B10.A ×  A.BY)F1 (H-2D  d/b) only in the H-2D subregion. Almost all of (B10.A(2R) 
×  A.BY)F1 mice developed a significant T  lymphocyte response to FV by day 10 after 
virus inoculation (Fig. 3 and Table i). This result indicated that the accelerated T 
lymphocyte response to FV mapped to the H-2D subregion and  appeared to be a 
recessive trait, as it was seen in H-2D  b~ but not in H-2D  d/b mice. These findings were 
analogous to the known recessive influence of these H-2D genotypes on recovery from 
high doses of FV in these same mouse strains (3, 4). 
Absence of a T Lymphocyte Response to FV in (BIO.A  ×  A)F1 Mice.  In order to study 
the FV-specific T  lymphocyte response of H-2D  d/a mice syngeneic AA41 FV leukemia 
cells were used as stimulator cells.  (B10.A ×  A.BY)F1  (H-2D  a/b) mice were positive, 
but surprisingly all (B 10.A × A)F1 H-2D  d/a mice were negative (Table II). This failure 
to respond to FV could be demonstrated in animals that exhibited normal responses 
to Con A (Fig. 1) and allogeneic cells in a mixed lymphocyte culture (data not shown). 
The region of H-2 controlling this response was analyzed by using H-2 recombinant 
mice. (B10.A(18R) ×  A.BY)F1 mice, which were identical to the (B10.A ×  A)F1 mice 
in the H-2D region but differed at all regions to the left of H-2D, were found to be 
good responders in the FV-specific T  lymphocyte proliferation assay (Table II). Thus, 
a region to the left of H-2D, perhaps the H-2I region, controlled this response, and in 
H-2 heterozygous mice (B10.A ×  A.BY)F1 responsiveness appeared to be dominant. 
Passively Transferred Immune T  Lymphocytes Induce Recovery  from  FV Leukemia  Only If 
Transferred Early After  Virus Inoculation.  To correlate the in vitro findings with previous 
in vivo results (3), we transferred FV-immune spleen cells into H-2D  d/b mice inocu- 
lated with a  high dose of FV  (2,000 FFU)  that  caused progressive leukemia in the 
majority of mice of this genotype (4).  Based on our findings in vitro, we predicted 
that  transfer of syngenic, immune spleen T  lymphocytes early after FV inoculation 
(day 6) would result in a high incidence of recovery as compared with transfer later 
after FV inoculation  (day 16). Our results confirmed this prediction in that passive 
transfer of immune spleen cells into animals inoculated with FV 6 d earlier resulted 
in high incidence of recovery (78%)  (Table III). However, the transfer of this same 
population  of immune spleen ceils into animals  that  received FV  16 d  before cell 
transfer did not result in an increased incidence of recovery as compared to control 
TABLE  II 
Absence of an FV-Specific T Lymphocyte Proliferatioe Response Maps to the K, I, or S 
Subregion of H-2*~ 
H-2 genotype  Responders/to- 
Strain  tal tested 
K  I  S  D 
(BtO.A x  A.BY)F1  k/b  k/b  d/b  d/b  6/8  (75%) 
(B10.A(18R)  X A/WySn)F1  b/k  b/k  b/d  d/d  5/6  (83%) 
(B10.A × A/WySn)F~  k/k  k/k  d/d  d/d  0/10 (0%) 
* Nylon wool  passed splenic lymphoeytes were cultured with and without mitomycin C- 
treated AA41 leukemia cells of (B10.A X A/WySn)Fa origin (H-2  a/a) for 4 d. After a  12-h 
pulse with 1/zCi [3H]thymidine,  cpm incorporated into DNA was measured. Mice with a 
Acpm above 3,000 cpm were considered responders. 
.~ Mice were tested 17-30 d after intravenous inoculation of 1,000 FFU of FV-B. 1742  H-2D CONTROLS  ANTI-FRIEND VIRUS T  CELL KINETICS 
TABL~ III 
Early  Transfer of Immune Spleen T Lymphocytes Induces Recovery From FV 
Leukemia 
Day of cell trans- 
Treatment of donor cells  Recovered/total:~  fer* 
6  None  14/18 (78%) 
6  C' only  20/31  (65%) 
6  a-Thy-1 +  C'  10/31  (32%) 
16  None  4/16 (25%) 
Control§  No cells transferred  5/19 (26%) 
* Recipient (BI0.A ×  A.BY)Fx mice were given 2,000  FFU ofFV i.v. on da~ 
0.  6 or  16 d  after virus inoculation, recipient animals were given 35  ×  10 
viable spleen cells intravenously from  (B10.A  ×  A.BY)F1  mice given  100 
FFU i.p. 16 d earlier ("immune spleen cell donors"). Spleen ceils were either 
untreated, treated with C' alone or treated with monoclonal anti-Thy- 1 plus 
C j" 
~" Mice recovering from FV-induced splenomegaly over total number tested. 
§ Control (B 10.A ×  A.BY)F1  animals were given 2,000 FFU of FV only. 
animals.  Furthermore,  the ceils responsible for inducing  recovery appeared to be T 
lymphocytes since recovery was reduced in 6-d recipients when the donor spleen cells 
were  depleted  of T  lymphocytes  by  treatment  with  anti-Thy-1  plus  complement 
(Table III). 
Discussion 
The data in the present report indicated that Friend virus-specific immune spleen 
T  lymphocytes could induce recovery from FV leukemia if given at 6 d, but not at  16 
d  following FV inoculation.  This finding emphasized the importance of immune T 
lymphocytes in the recovery process (2, 8), and also demonstrated that the timing of 
the  immune  response  relative  to  the  virus  infection  was  of  critical  importance. 
Furthermore, it was found that a  significant difference existed between H-2D  b/b and 
H-2D  d/b  mice  in  the  kinetics  of  the  development  of  the  FV-specific  in  vitro  T 
lymphocyte proliferative response. This influence on the response kinetics was mapped 
to the  H-2D region,  and  correlated  exactly with  the  known  influence  of an  H-2D 
gene, Rfv-1, on spontaneous recovery from FV leukemia (3).  This suggested that the 
mechanism  by which  Rfv-1  influenced  recovery might  operate  by controlling  the 
kinetics of development of the T  lymphocyte response to FV. An early T  lymphocyte 
response might lead to recovery by restricting virus spread and eliminating leukemia 
ceils early in the course of the disease when the leukemia cell burden was low (15). 
Lack of an early response to FV in H-2D  d/b might also could explain the previously 
observed influence of virus dose on recovery in  mice with  this genotype  (4).  These 
mice would appear to have the mechanisms necessary for recovery since after low FV 
doses they produce anti-FV CTL (2), 2 can recover from leukemia (4), and their spleen 
T  lymphocytes can adoptively transfer ability to recover (Table III). However, after 
use of high FV inocula, many more cells would be infected and transformed initially 
leading  to  a  large  virus  and  leukemia cell  burden  earlier after inoculation.  In  this 
situation, the observed delay in the anti-FV T-lymphocyte response might be a critical 
disadvantage that could not be overcome in H-2D  a/b mice. In contrast, the more rapid 
response of H-2D b/b  mice appeared capable of eliminating  this  increased  leukemia BRITT ET AL.  1743 
cell burden. 
The mechanism by which  H-2D might  influence the kinetics of a  T  lymphocyte 
response is unknown. In several systems, the H-2K or H-2D regions appear to control 
the generation of CTL (16,  17). In these instances, nonresponsiveness was dominant, 
similar to our results. However, in no case previously has the difference been found to 
be a  kinetic one.  It is possible that, based on their increased quantity of H-2D  b cell 
surface antigen, H-2D  b/b FV leukemia cells might induce a more rapid FV-specific T 
lymphocyte response than  H-2D  d/b ceils.  However, our previous attempts to detect 
such increased immunogenicity in vivo failed to detect any differences (8). Therefore, 
we feel this is an unlikely explanation  for our present  findings.  Alternatively, these 
results might be explained by a  quantitative  difference in  the number of precursor 
cells involved at a critical point in the immune network leading to generation of FV- 
specific CTL.  Future  studies  will  attempt  to evaluate quantitatively  some of these 
precursor cell populations. 
Use of the in vitro T  lymphocyte proliferative assay has allowed us to identify a 
second H-2-associated effect on the FV immune response.  (B10.A ×  A)FI mice were 
nonresponders at both early and late times after FV inoculation.  Responsiveness in 
this case was dominant, and mapped to the left of the H-2D region  (Table II). The 
action of this gene appeared consistent with the effects of a typical I-region immune 
response  gene  (18).  Such  a  genetic  effect had  been  predicted  previously, based on 
studies of FV tumor rejection  (19)  and recovery from FV leukemia (4), where it was 
referred to as the Rfv-2 gene.  Lack of in vitro responsiveness in the  (B10.A  ×  A)F1 
mice  went  along  with  the  absence  of  spontaneous  recovery  from  FV  leukemia. 
However, our preliminary studies indicate that nonresponsiveness to FV in these mice 
may be highly virus-specific because we have observed a  high incidence of recovery 
after inoculation of Moloney leukemia virus pseudotypes of the defective spleen focus- 
forming virus component of the Friend virus complex (data not shown). 
The  role  of  immunosuppression  in  the  effects  reported  here  is  not  clear.  FV 
inoculation of certain mouse strains (BALB/c and DBA/2)  leads to profound immu- 
nosuppression (10,  12). However, in the F1 mice used throughout this report, we found 
no evidence for suppression of the T-lymphocyte response to Con A, even in mice that 
did not respond to FV at any time after FV inoculation. We used nylon wool-filtered 
splenic T  lymphocytes in all our experiments, and it is possible that some suppressive 
cell populations were removed by this step  (13).  If suppressor cells were responsible 
for either the late response or absence of a  response to FV in certain F1 mice, these 
cells might function in vivo before the time of nylon wool separation of spleen cells for 
analysis. However, our previous in vivo adoptive cell transfer experiments (8), as well 
as the present  data  (Table III), do not support  this  interpretation.  Suppressor cells 
might also remain in the nylon wool-purified populations. But if so, they must either 
be FV-specific in their effects and/or too weak in potency to suppress responsiveness 
to Con A. Appropriate cell mixing experiments will have to be carried out to evaluate 
these possibilities. 
Summary 
A Friend virus (FV)-specific T  lymphocyte proliferation assay was used to compare 
the T  lymphocyte responses of H-2 congenic  mice that  differed  in  their  ability to 
recover from FV leukemia after inoculation of high virus doses. Gene(s) of the H-2D 1744  H-2D  CONTROLS  ANTI-FRIEND VIRUS T  CELL KINETICS 
region influenced  the kinetics of this response such  that  H-2D  b/b homozygous mice 
were positive 6-8 d  earlier than H-2D  d/b mice. This correlated with the Rfv-1, H-2D- 
linked influence on recovery from FV by these mice, and also appeared to explain the 
prominent effect of virus dose on recovery incidence. These findings were supported 
by  the  ability of  passively  transferred  immune  splenic  T  lymphocytes  to  induce 
recovery from leukemia at 6 d after FV inoculation, but not at 16 d. H-2  a/" mice were 
found  to be unresponsive in the FV-speeific T  lymphocyte proliferation assay. This 
effect mapped to the left of H-2D, possibly in the H-2I region, and may be an in vitro 
manifestation of the Rfv-2 gene.  No evidence for nonspecific immunosuppression of 
the T  lymphocyte response to concanavalin A was observed in any of the H-2 congenic 
Fx mice studied. 
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